1.
Rev Mal Respir
; 31(9): 867-70, 2014 Nov.
Article
in French
| MEDLINE
| ID: mdl-25433594
Subject(s)
HTLV-I Infections/complications , Lung Diseases, Parasitic/complications , Pneumonia/complications , Strongyloidiasis/complications , Animals , Coinfection , HTLV-I Infections/parasitology , HTLV-I Infections/pathology , Humans , Lung Diseases, Parasitic/pathology , Lung Diseases, Parasitic/virology , Male , Middle Aged , Pneumonia/parasitology , Pneumonia/pathology , Pneumonia/virology , Strongyloides stercoralis/isolation & purification , Strongyloidiasis/pathology , Strongyloidiasis/virology
2.
Ann Trop Med Parasitol
; 102(8): 693-8, 2008 Dec.
Article
in English
| MEDLINE
| ID: mdl-19000386
ABSTRACT
There are no established guidelines for the treatment of disseminated strongyloidiasis in immunosuppressed patients, and many different treatment regimens have been used. Here, the case of a 48-year-old, HIV-positive, Congolese man, who was hospitalized for disseminated tuberculosis but developed life-threatening disseminated strongyloidiasis, is described. This patient died, with relapsing disseminated strongyloidiasis, 3 months after being treated with ivermectin. The reasons for this poor outcome and the various treatment options for strongyloidiasis in HIV-infected patients are discussed.
Subject(s)
Antinematodal Agents/therapeutic use , HIV Seropositivity , Ivermectin/therapeutic use , Lung Diseases, Parasitic/drug therapy , Strongyloides stercoralis , Strongyloidiasis/drug therapy , Animals , Fatal Outcome , Humans , Immunocompromised Host , Lung Diseases, Parasitic/virology , Male , Middle Aged , Recurrence , Strongyloidiasis/virology , Tuberculosis/parasitology , Tuberculosis/virology
3.
Lab Anim (NY)
; 34(8): 24-7, 2005 Sep.
Article
in English
| MEDLINE
| ID: mdl-16136071
